APAbigail J. Porzucek

Abigail J. Porzucek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abigail J. Porzucek has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccine

    by Luciana Conde, Valter Monteiro, Joao C.R. Freitas, Jameson Crandell, Lauren Lawres, Fernanda Tana, Mallery I. Breban, Fahima Akther, Jordan Polster, Abigail Porzucek, et al.

    Dengue causes over 390 million annual infections globally. Qdenga (TAK-003), the only widely available dengue vaccine, has an incompletely defined immunological profile. We performed longitudinal immunological profiling of 110 adults from a dengue-endemic region, including older adults (≥65 years), to assess the effects of immune imprinting and vaccine design on humoral and cellular immunity. Qdenga elicited B and T cell activation across groups but generated serostatus-dependent, serotype-skewed antibody responses. Only 8% of DENV-naïve individuals developed tetravalent neutralizing responses, whereas one-third responded to a single serotype, predominantly DENV-2, the vaccine backbone. DENV-exposed individuals mounted broader responses shaped by preexisting immunity, yet DENV-4 neutralization remained consistently poor. Neutralizing antibody titers plateaued after the first dose, with no increase following the second. These findings clarify why balanced tetravalent immunity is rarely achieved with Qdenga and demonstrate that both immune imprinting and vaccine backbone limit the breadth and magnitude of the responses. This has important implications for deployment, long-term protection in naive populations, and DENV-4–targeted boosters.


  • Open Access

    Standardizing annual dengue intensity reveals global drivers of transmission

    by Abigail J. Porzucek, Rafael Lopes, Yi Ting Chew, Ke Li, Oliver J. Brady, Joshua L. Warren, Colin J. Carlson, Daniel M. Weinberger, Nathan D. Grubaugh

    Dengue incidence is increasing due to climate change and globalization, as well as enhanced case ascertainment. Despite the increasing transmission intensity of dengue virus, there is no standardized measure of disease burden, nor a standardized outbreak definition. Without such measures, it is difficult to understand how transmission patterns are changing over time and to identify what drives these changes globally. To address these problems, we developed a globally standardized metric of dengue burden, which we refer to as the Relative Intensity Score (RISc). RISc is an annual, country-level metric that measures short-term aberrations in dengue incidence relative to location- and time-specific baselines. We derived RISc estimates for 57 countries from 1990-2023 and then used RISc to identify years in which each country experienced outbreak-level transmission. Using these measures, we then examined patterns of RISc over time and found that years with increased RISc tend to cluster together, suggesting that changes in intensity are sustained through multi-year cycles. Finally, we identified factors associated with increased RISc on global and regional scales and found that increases in temperature were associated with the greatest increases in intensity. In sum, this study provides a globally standardized measure of dengue burden and demonstrates how this metric can be utilized to uniformly identify outbreak occurrence, track changing epidemiologic patterns, and identify environmental factors driving changes in intensity.